Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.20.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities    
Net income (loss) $ (3,273,581) $ 808,931
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 565,208 482,497
Impairment loss 1,607,797  
Deferred income taxes, net (17,852) (25,731)
Loss on derivatives 12,195  
Loss on extinguishment of debt 10,480 3,988
Provision for bad debts and inventory obsolescence 16,293 2,852
Gain on involuntary conversion of assets (1,340) (2,800)
Share-based compensation expense 81,009 82,070
Net foreign currency adjustments 3,746 (4,326)
Changes in operating assets and liabilities:    
Accounts receivable, net (12,103) (12,741)
Inventories 12,757 (4,681)
Prepaid expenses and other assets 79,915 (31,926)
Accounts payable 11,536 (86,525)
Accrued expenses and other liabilities (180,126) (27,504)
Advance ticket sales (834,560) 262,938
Net cash provided by (used in) operating activities (1,918,626) 1,447,042
Cash flows from investing activities    
Additions to property and equipment, net (873,142) (615,985)
Cash received on settlement of derivatives   289
Cash paid on settlement of derivatives (31,520) (556)
Other 3,047 5,039
Net cash used in investing activities (901,615) (611,213)
Cash flows from financing activities    
Repayments of long-term debt (888,800) (2,882,354)
Proceeds from long-term debt 5,225,090 2,652,000
Common share issuance proceeds, net 719,094  
Proceeds from employee related plans 5,557 18,203
Net share settlement of restricted share units (15,334) (20,935)
Purchases of treasury shares   (349,860)
Early redemption premium (1,376) (117)
Deferred financing fees (117,388) (9,359)
Net cash provided by (used in) financing activities 4,926,843 (592,422)
Effect of exchange rates on cash and cash equivalents (3,267)  
Net increase in cash and cash equivalents 2,103,335 243,407
Cash and cash equivalents at beginning of period 252,876 163,851
Cash and cash equivalents at end of period $ 2,356,211 $ 407,258